Page 3 - Les meilleurs doctors traitant la maladie suivante : Cancer du cerveau - TOP -95 des médecins

Le professeur associé Nail Paksoy apporte une vaste expertise en oncologie provenant de l'Institut d'oncologie de l'Université d'Istanbul et de l'hôpital Medipol Bahçelievler.

• Certifié par l'ESMO en oncologie médicale
• Participation à plus de 8 essais cliniques internationaux pour les cancers avancés
• Publication de plus de 30 articles de recherche sur les traitements innovants contre le cancer
• Spécialisation dans les thérapies ciblées et les approches d'oncologie de précision

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Le professeur Gül Alco est une experte en radio-oncologie à l'Université Medipol d'Istanbul, avec plus de 20 ans d'expérience.

• Se spécialiser en radio-oncologie pour le cancer du cerveau
• Professeur aux universités Demiroglu Bilim et Medipol
• Diplômée de la faculté de médecine de l'Université d'Istanbul

Le Dr Inta Jaunalksne est spécialisée en virothérapie, l'un des domaines les plus récents de l'immunologie, avec plus de 30 ans d'expérience.

• Chef du centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômée de l'Institut médical de Riga avec un internat en médecine interne
• Se concentrer sur les traitements immunologiques innovants pour le cancer du cerveau

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Le Dr Salman possède une vaste expertise en oncologie acquise dans des institutions prestigieuses telles que le Memorial Sloan Kettering Cancer Center et le Moffitt Cancer Center.

• Plus de 15 ans de spécialisation en oncologie médicale
• Expert en thérapies ciblées et en immunothérapie
• Membre du conseil d'administration de la Société Turque d'Oncologie Médicale
• Actif dans la recherche clinique et les traitements expérimentaux
• Traiter des cas de cancer rares et complexes

Dr. David Kuczer is a specialist in radio-oncology with many years of experience in cancer diagnosis and treatment. He offers fast access to precise radiotherapy based on current scientific standards.

He is a member of the Cancer Center at the Vienna Private Clinic. He presents each patient to the in-house tumor board. This allows an interdisciplinary discussion by an internationally renowned team and helps select the best treatment.

All radiation treatments are provided in close cooperation with Amethyst Radiotherapy at the Vienna Private Clinic.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Spécialisé dans le traitement des tumeurs cérébrales à l'Hôpital International Medicalpoint, avec une solide formation en oncologie de l'Université Hacettepe.

• Expérimenté dans le traitement de divers cancers, y compris les tumeurs cérébrales
• Formé à l'Université Hacettepe – un centre d'oncologie de premier plan
• Membre de l'ESMO et de l'Association Turque d'Oncologie Médicale

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Spécialisé dans la chirurgie endoscopique et l'ablation de tumeurs cérébrales au Samsung Medical Center – l'un des principaux hôpitaux de neurochirurgie en Corée du Sud.

• Traiter les patients pédiatriques et adultes
• Expertise dans les tumeurs cérébrales bénignes et malignes
• Maîtriser les techniques de radiochirurgie

Pionnier de la recherche sur les syndromes neurologiques paranéoplasiques – Le Dr Graus en a défini les critères diagnostiques. Travaille à l'Hospital Quiron Barcelona.

• 39 ans d'expérience en neuro-oncologie
• Spécialisé dans les gliomes et les lymphomes cérébraux primitifs
• Ancien chef du service de neurologie de l'Hospital Clinic
• Fondateur et ancien président de l'EANO
• Doctorat honoris causa de l'Université de Lyon

Spécialisé en radiothérapie pour le cancer du cerveau, le Dr Michael Van Kampen propose des traitements ciblés à la Clinique Nordwest.

• Expertise ciblée en radiothérapie pour les tumeurs cérébrales
• Travailler à la Clinique Nordwest – un centre d'oncologie de premier plan
• Personnaliser les plans de traitement selon les besoins de chaque patient

Le Dr Jablonski-Perec a été formée au célèbre centre de cancérologie Sloan-Kettering de New York et est devenue chef du service d'oncologie du centre médical Hadassah.

• Plus de 25 ans à la tête de services d'oncologie et de centres de traitement
• Professeur d'oncologie à l'Université hébraïque – l'une des meilleures facultés de médecine d'Israël
• Chef du centre de traitement du cancer du sein depuis 1998
• Membre de plusieurs sociétés internationales de cancérologie
• Récipiendaire d'une bourse prestigieuse de la faculté de médecine Hadassah